OTCMKTS:POLXF

Polydex Pharmaceuticals Stock Forecast, Price & News

$0.93
0.00 (0.00 %)
(As of 09/23/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.93
$0.93
50-Day Range
$0.93
$0.99
52-Week Range
$0.87
$1.14
Volume1,000 shs
Average Volume3,525 shs
Market Capitalization$3.19 million
P/E RatioN/A
Dividend YieldN/A
Beta0.56
30 days | 90 days | 365 days | Advanced Chart
Receive POLXF News and Ratings via Email

Sign-up to receive the latest news and ratings for Polydex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.


Polydex Pharmaceuticals logo

About Polydex Pharmaceuticals

Polydex Pharmaceuticals Ltd. engages in the manufacture and sale of bulk quantities of dextran and derivative products to large pharmaceutical companies. It develops and market biotechnology-based products for the human pharmaceutical market. The firm focuses on Dextran and derivative products, including Iron Dextran and Dextran Sulphate and other specialty chemicals. The company was founded by Thomas C. Usher on June 14, 1979 and is headquartered in Toronto, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.22 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Polydex Pharmaceuticals (OTCMKTS:POLXF) Frequently Asked Questions

What stocks does MarketBeat like better than Polydex Pharmaceuticals?

Wall Street analysts have given Polydex Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Polydex Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Polydex Pharmaceuticals' next earnings date?

Polydex Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, December 21st 2021.
View our earnings forecast for Polydex Pharmaceuticals
.

How has Polydex Pharmaceuticals' stock price been impacted by COVID-19 (Coronavirus)?

Polydex Pharmaceuticals' stock was trading at $1.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, POLXF shares have decreased by 12.3% and is now trading at $0.93.
View which stocks have been most impacted by COVID-19
.

Who are Polydex Pharmaceuticals' key executives?

Polydex Pharmaceuticals' management team includes the following people:
  • George G. Usher, Chairman, President & Chief Executive Officer
  • Sharon L. Wardlaw, Chief Operating Officer, Secretary & Treasurer
  • David Jamestee, Chief Financial Officer
  • Linda Hughes, Head-Media & Public Relations

What is Polydex Pharmaceuticals' stock symbol?

Polydex Pharmaceuticals trades on the OTCMKTS under the ticker symbol "POLXF."

How do I buy shares of Polydex Pharmaceuticals?

Shares of POLXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Polydex Pharmaceuticals' stock price today?

One share of POLXF stock can currently be purchased for approximately $0.93.

How much money does Polydex Pharmaceuticals make?

Polydex Pharmaceuticals has a market capitalization of $3.19 million and generates $4.86 million in revenue each year.

How many employees does Polydex Pharmaceuticals have?

Polydex Pharmaceuticals employs 22 workers across the globe.

What is Polydex Pharmaceuticals' official website?

The official website for Polydex Pharmaceuticals is www.polydex.com.

Where are Polydex Pharmaceuticals' headquarters?

Polydex Pharmaceuticals is headquartered at 421 COMSTOCK ROAD, TORONTO A6, M1L 2H5.

How can I contact Polydex Pharmaceuticals?

Polydex Pharmaceuticals' mailing address is 421 COMSTOCK ROAD, TORONTO A6, M1L 2H5. The company can be reached via phone at (416) 755-2231 or via email at [email protected].


This page was last updated on 9/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.